Hydrocortisone and Fludrocortisone for Critical Illness-related Corticosteroid Insufficiency (HORNbILL)
Sponsor: Assistance Publique - Hôpitaux de Paris
A PHASE3 clinical study on Critical Illness Related Corticosteroids Insufficiency, this trial is actively recruiting participants. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 14 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
May 2025 — Present [monthly]
Recruiting PHASE3
-
Sep 2024 — May 2025 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Jul 2023 — Jul 2024 [monthly]
Recruiting PHASE3
-
Dec 2022 — Jul 2023 [monthly]
Recruiting PHASE3
▶ Show 9 earlier versions
-
Nov 2022 — Dec 2022 [monthly]
Recruiting PHASE3
-
Mar 2022 — Nov 2022 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jan 2022 — Mar 2022 [monthly]
Not Yet Recruiting PHASE3
-
Nov 2021 — Jan 2022 [monthly]
Not Yet Recruiting PHASE3
-
Oct 2021 — Nov 2021 [monthly]
Not Yet Recruiting PHASE3
-
Sep 2021 — Oct 2021 [monthly]
Not Yet Recruiting PHASE3
-
Mar 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jun 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
For direct contact, visit the study record on ClinicalTrials.gov .